MedPath

The effect of alcohol on perceived trustworthiness: moderation and oxytocin-induced mediatio

Not Applicable
Conditions
Trustworthiness of presented faces in relation to alcohol consumption
Registration Number
DRKS00026599
Lead Sponsor
Zentralinstitut für Seelische Gesundheit Mannheim (ZI)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
78
Inclusion Criteria

Male gender; social drinker (regular consumption of alcohol with breath alcohol levels of at least 1.5 per mille, preferably in social contexts); = 18 years of age; Last meal eaten 3 hours before the start of the survey; Last cigarette smoked 3 hours before start of survey; On the day of the survey, the subject refrains from sexual activity; On the day of the survey, the subject refrains from increased physical activity; On the day of the survey, the subject does not consume more than 0.5 liters of fluid; On the day of the survey, the subject does not expose him/herself to excessive stress

Exclusion Criteria

Current and/or previous presence of a diagnosed psychotic or depressive mental illness; Current and/or previous presence of a diagnosed alcohol-related addictive disorder (assessment using the AUDIT; Rumpf, H.J., Meyer, C., Hapke, U., John, U., 2003. German version of the Alcohol Use Disorders Identification Test (AUDIT-G-L). In: Glöckner-Rist, A., Rist, F., Küfner, H. (Eds.), Electronic Handbook on Survey Instruments in the Field of Addiction (EHES). Version 3.00. Center for Surveys, Methods and Analyses, Mannheim); Current psychotherapeutic treatment of a mental illness; Current use of medications that may interact with alcohol (e.g., antidepressants, sedatives); Current presence of a serious physical disease: oncological therapy during the past 10 years, metabolic disease (Addison's disease, Cushing's disease, hypogonadism, testosterone treatment), neurological disease (multiple sclerosis, M. Parkinson's disease, amyotrophic lateral sclerosis, stroke during the past 5 years, traumatic brain disease with persistent neurological deficit), acute cardiovascular disease (first manifestation during the past 4 weeks), myocardial infarction, decompensated heart failure, renal failure, infectious disease currently under treatment, rheumatologic disease; Use of illicit drugs in more than 15 instances over a lifetime (cannabis excluded); Use of illicit drugs in the last 7 days (cocaine, opioids, amphetamines; cannabis excluded); Known intolerance to substances containing alcohol (alcohol sensitivity or alcohol intolerance); use of steroid hormone preparations (incl. anabolic steroids) within the last 12 months.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjects' perceived trustworthiness regarding presented faces, measured via behavioral test.
Secondary Outcome Measures
NameTimeMethod
Oxytocin concentration in the salvia.
© Copyright 2025. All Rights Reserved by MedPath